Dr. Greg Marchand has 137 indexed works to his name — 97 peer-reviewed articles, 35 conference presentations, 4 book chapters and textbooks, and 1 patent listing — with more than 1,200 citations, an h-index of 18 and an i10-index of 26 (Google Scholar).
The great majority of that output is systematic review and meta-analysis. Every review is prospectively registered with PROSPERO, reported to PRISMA standards, and appraised with the Cochrane Risk of Bias 2 (RoB 2) tool where randomized trials are included. Read exactly how the reviews are conducted →
Verified researcher identifiers: ORCID 0000-0003-4724-9148 · Google Scholar · Scopus · Web of Science AAG-7878-2021 · ResearchGate · PubMed
Preferred affiliation statement: Marchand Institute for Minimally Invasive Surgery, Mesa, Arizona, USA
Media and academic inquiries: see the Newsroom and Press Kit or propose a collaboration.
This is the complete, continuously updated research output of Dr. Greg J. Marchand and his research team — peer-reviewed journal articles, conference presentations and abstracts, book chapters and patents. Every record links out to its DOI, PubMed entry or full text where one exists.
Use the search box to look up a title, author, journal, DOI or PubMed ID, or narrow the list by publication type and year. You can also subscribe by RSS to be notified whenever new work is added, and export any citation in BibTeX or RIS format from its individual page.
137 publications found RSS feed
Effect of Improved Vaginal Manipulator on Laparoscopic Sacrocolpopexy
Adnexal masses suspected to be benign treated with laparoscopy
JSLS : Journal of the Society of Laparoendoscopic Surgeons
Laparoscopic Unilateral Salpingo-Oophorectomy, Bagging & Vaginal Morcellation
Unnecessary Laparotomy Avoidance—Outcome of 257 Consecutive Adnexal Masses of 8–13cm on Pre-Operative Ultrasound Treated with Laparoscopic Adnexectomy, Bagging and Colpotomy
Journal of Minimally Invasive Gynecology
Outcome of 783 Consecutive Hysterectomies for Benign Indication-Likelihood of Competing a Minimally invasive Hysterectomy Based on Patient’s Body Mass Index
Laparoscopic Hysterectomy and Vaginal Morcellation
Laparoscopic Supracervical Hysterectomy and Vagino-Cervico-Sacropexy
Cost-Effective, Outpatient-Safe, Minilaparotomy Myomectomy
Abstract: Laparoscopic Cervical Cerclage in 18-weeks Pregnant Uterus, Abstract 10.108, Presented at the 19th Annual Meeting of the Society of Laparoendoscopic Surgeons, New York, also included in Supplement issue of Journal
Video: Laparoscopic cervical cerclage in 18-weeks pregnant uterus
Safe laparoscopic removal of a 3200 gram fibroid uterus
JSLS : Journal of the Society of Laparoendoscopic Surgeons
Patient Selection Criteria for Outpatient Myomectomy via Mini-laparotomy
Citation Impact
Dr. Marchand’s published research is cited by other investigators in the medical literature. The citations below are references to his work in journals published by other groups. They are not his own publications.
Cited in all three leading general medical journals
- New England Journal of Medicine. Gorelick DA. Cannabis-Related Disorders and Toxic Effects. N Engl J Med. 2023;389(24):2267-2275.
- JAMA. Hsu M, Shah A, Jordan A, Gold MS, Hill KP. Therapeutic Use of Cannabis and Cannabinoids: A Review. JAMA. 2026;335(4):345.
- The BMJ. Solmi M, De Toffol M, Kim JY, et al. Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies. BMJ. 2023;382:e072348.
All three cite the same paper by Dr. Marchand and colleagues: Marchand G, Masoud AT, Govindan M, et al. Birth outcomes of neonates exposed to marijuana in utero: a systematic review and meta-analysis. JAMA Network Open. 2022;5(1):e2145653.
Cited in national practice guidance
A 2021 meta-analysis co-authored by Dr. Marchand comparing salpingectomy with tubal ligation (Mills K, Marchand G, Sainz K, et al. Am J Obstet Gynecol. 2021;224(3):258-265.e4) was cited in the Canadian Medical Association Journal’s practice guidance on opportunistic salpingectomy for ovarian cancer risk reduction (CMAJ. 2024;196(22):E765). It appears there alongside Guideline No. 366 of the Society of Obstetricians and Gynaecologists of Canada and ACOG Committee Opinion No. 774, as one of six supporting sources and the only systematic review or meta-analysis among them. The same paper is cited in Endocrine Reviews (2025;46(5):736-759) in guidance on contraceptive selection for the endocrine patient.
Thirty-six citations in first-rank journals
As of August 2026, Dr. Marchand’s research has been cited thirty-six times in journals of the first rank, across four groups:
- JAMA network. JAMA, JAMA Internal Medicine, JAMA Pediatrics, JAMA Health Forum, and JAMA Network Open, including the invited commentary that accompanied the 2022 meta-analysis.
- Lancet titles. The Lancet Public Health, The Lancet Global Health, The Lancet Regional Health – Americas, and eClinicalMedicine.
- Nature titles. Nature Reviews Immunology, Nature Reviews Microbiology, Nature Reviews Disease Primers, and Nature Communications. The Nature Reviews Disease Primers monograph on ovarian cancer cites work published by Dr. Marchand in 2012.
- Other leading journals. Pediatrics, CMAJ, the Medical Journal of Australia, Endocrine Reviews, Molecular Psychiatry, eBioMedicine, BMC Medicine, BMJ Global Health, Cellular & Molecular Immunology, and the Journal of General Internal Medicine.
Citation data compiled from PubMed, Europe PMC, Semantic Scholar and OpenCitations. Verified 28 August 2026.